What is Bangs Laboratories?
Bangs Laboratories, Inc. operates as a critical infrastructure provider within the medical diagnostics and biopharma sectors. The company specializes in the manufacturing of high-quality microsphere-based reagents and analytical instrument calibrators. With a legacy spanning over 35 years, the organization has established itself as a premier supplier of polymer, silica, and magnetic microspheres. These components are essential for the development of sophisticated assays and the calibration of complex laboratory instrumentation. By providing custom solutions tailored to specific research requirements, the company supports a diverse clientele ranging from clinical laboratories to large-scale biopharmaceutical enterprises, maintaining a reputation for rigorous quality control and technical innovation.
How much funding has Bangs Laboratories raised?
Bangs Laboratories has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Bangs Laboratories
PPP
Public-Private Partnership
What's next for Bangs Laboratories?
Looking ahead, the strategic deployment of this capital will likely focus on expanding the company's manufacturing capacity and deepening its penetration into emerging diagnostic markets. As the demand for accurate, reliable, and high-throughput analytical data grows, Bangs Laboratories is poised to capitalize on its technical moat. The firm is expected to prioritize the development of next-generation magnetic particles and advanced surface-functionalized microspheres to meet the evolving needs of the life sciences sector. This growth phase will likely involve optimizing supply chain efficiencies and potentially exploring new partnerships to broaden its global distribution network, thereby reinforcing its status as an indispensable partner in the diagnostic and research ecosystem.
See full Bangs Laboratories company page
